On Sept. 26, 2025, Sanofi US announced a broad expansion of its Insulins Valyou Savings Program by offering a 30-day supply of any Sanofi insulin for $35 to all patients in the US with a valid prescription.

The program, first created for people without health insurance, will be available to all Americans regardless of insurance status, including those with commercial insurance or Medicare, to ensure affordable access to these critical medicines.

Sanofi’s Insulins Valyou Savings Program works at most pharmacies across the US, including independent and rural pharmacies, without creating complex hurdles for patients.

The expanded program will cover all Sanofi insulins and will be implemented nationwide. This initiative builds on Sanofi’s longstanding commitment to access and affordability.

Under this expansion, every American will be able to purchase any combination, type, and quantity of Sanofi insulins with a valid prescription for a fixed monthly price of $35.